The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
eFFECTOR Therapeutics, Inc. | Common Stock | 28202V108 | 8,493 | 1,025,697 | SH | SOLE | 1,025,697 | 0 | 0 | ||
Evolv Technologies Holdings, Inc. | Common Stock | 30049H102 | 8,121 | 1,820,866 | SH | SOLE | 1,820,866 | 0 | 0 | ||
PMV Pharmaceuticals, Inc. | Common Stock | 69353Y103 | 22,851 | 989,232 | SH | SOLE | 989,232 | 0 | 0 | ||
Sera Prognostics, Inc. | Common Stock | 81749D107 | 4,406 | 641,361 | SH | SOLE | 641,361 | 0 | 0 | ||
Cyteir Therapeutics, Inc. | Common Stock | 23284P103 | 28,136 | 2,474,572 | SH | SOLE | 2,474,572 | 0 | 0 | ||
Homology Medicines, Inc. | Common Stock | 438083107 | 233 | 64,000 | SH | SOLE | 64,000 | 0 | 0 | ||
Precision BioSciences, Inc. | Common Stock | 74019P108 | 8,317 | 1,123,913 | SH | SOLE | 1,123,913 | 0 | 0 | ||
ionQ, Inc. | Common Stock | 46222L108 | 69,256 | 4,147,081 | SH | SOLE | 4,147,081 | 0 | 0 | ||
Selecta Biosciences, Inc. | Common Stock | 816212104 | 2,812 | 862,543 | SH | SOLE | 862,543 | 0 | 0 | ||
Spero Therapeutics, Inc. | Common Stock | 84833T103 | 3,988 | 249,070 | SH | SOLE | 249,070 | 0 | 0 | ||
Centessa Pharmaceuticals plc | Sponsored ADS | 152309100 | 26,370 | 2,341,891 | SH | SOLE | 2,341,891 | 0 | 0 | ||
Aerovate Therapeutics Inc. | Common Stock | 008064107 | 7,118 | 603,762 | SH | SOLE | 603,762 | 0 | 0 | ||
DICE Therapeutics Inc. | Common Stock | 23345J104 | 13,584 | 536,693 | SH | SOLE | 536,693 | 0 | 0 | ||
Graphite Bio | Common Stock | 38870X104 | 5,050 | 406,308 | SH | SOLE | 406,308 | 0 | 0 | ||
Landos Biopharma, Inc. | Common Stock | 515069102 | 8,772 | 1,827,478 | SH | SOLE | 1,827,478 | 0 | 0 | ||
Vor Biopharma Inc. | Common Stock | 929033108 | 4,354 | 374,714 | SH | SOLE | 374,714 | 0 | 0 |